BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 9020269)

  • 1. Prognostic implication of creatine kinase elevation following elective coronary artery interventions.
    Kong TQ; Davidson CJ; Meyers SN; Tauke JT; Parker MA; Bonow RO
    JAMA; 1997 Feb; 277(6):461-6. PubMed ID: 9020269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic importance of creatine kinase and creatine kinase-MB after primary percutaneous coronary intervention for ST-elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; de Boer MJ; Dambrink JH; Hoorntje JC; Gosselink AT; Suryapranata H; van't Hof AW;
    Am Heart J; 2008 Apr; 155(4):673-9. PubMed ID: 18371475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
    Bertinchant JP; Polge A; Ledermann B; Genet L; Fabbro-Peray P; Raczka F; Brunet J; Poirey S; Wittenberg O; Pernel I; Nigond J
    Am J Cardiol; 1999 Jul; 84(1):51-7. PubMed ID: 10404851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term clinical events following creatine kinase--myocardial band isoenzyme elevation after successful coronary stenting.
    Saucedo JF; Mehran R; Dangas G; Hong MK; Lansky A; Kent KM; Satler LF; Pichard AD; Stone GW; Leon MB
    J Am Coll Cardiol; 2000 Apr; 35(5):1134-41. PubMed ID: 10758952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between minor elevations of creatine kinase-MB level and mortality in patients with acute coronary syndromes without ST-segment elevation. PURSUIT Steering Committee. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.
    Alexander JH; Sparapani RA; Mahaffey KW; Deckers JW; Newby LK; Ohman EM; Corbalán R; Chierchia SL; Boland JB; Simoons ML; Califf RM; Topol EJ; Harrington RA
    JAMA; 2000 Jan; 283(3):347-53. PubMed ID: 10647797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Troponin T, Troponin I and CK-MB (mass) in the detection of periprocedural myocardial damage after coronary angioplasty].
    La Vecchia L; Bedogni F; Finocchi G; Mezzena G; Martini M; Sartori M; Castellani A; Soffiati G; Vincenzi M
    Cardiologia; 1997 Apr; 42(4):405-13. PubMed ID: 9244645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Creatine kinase-MB elevation after coronary intervention correlates with diffuse atherosclerosis, and low-to-medium level elevation has a benign clinical course: implications for early discharge after coronary intervention.
    Kini A; Marmur JD; Kini S; Dangas G; Cocke TP; Wallenstein S; Brown E; Ambrose JA; Sharma SK
    J Am Coll Cardiol; 1999 Sep; 34(3):663-71. PubMed ID: 10483945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Creatine kinase-MB fraction elevation after percutaneous coronary intervention in patients with chronic renal failure.
    Gruberg L; Mehran R; Waksman R; Dangas G; Fuchs S; Wu H; Kent KM; Pichard AD; Satler LF; Stone GW; Leon MB
    Am J Cardiol; 2001 Jun; 87(12):1356-60. PubMed ID: 11397353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
    Kini AS; Lee P; Marmur JD; Agarwal A; Duffy ME; Kim MC; Sharma SK
    Am J Cardiol; 2004 Jan; 93(1):18-23. PubMed ID: 14697460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CK-MB elevation after percutaneous or surgical revascularization and three-year mortality.
    Brener SJ; Lytle BW; Schneider JP; Ellis SG; Topol EJ
    J Am Coll Cardiol; 2002 Dec; 40(11):1961-7. PubMed ID: 12475456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Troponin I elevation and cardiac events after percutaneous coronary intervention.
    Ricciardi MJ; Davidson CJ; Gubernikoff G; Beohar N; Eckman LJ; Parker MA; Bonow RO
    Am Heart J; 2003 Mar; 145(3):522-8. PubMed ID: 12660677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The diagnosis of myocardial damage during coronary angioplasty by the analysis of the isoforms of the enzyme creatine kinase MB].
    Vázquez Rodríguez JM; Hossein-Nia M; Chester M; Leatham E; Holt DW; Kaski JC
    Rev Esp Cardiol; 1995 Aug; 48(8):528-36. PubMed ID: 7644806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic implications of creatine kinase elevation after primary percutaneous coronary intervention for acute myocardial infarction.
    Halkin A; Stone GW; Grines CL; Cox DA; Rutherford BD; Esente P; Meils CM; Albertsson P; Farah A; Tcheng JE; Lansky AJ; Mehran R
    J Am Coll Cardiol; 2006 Mar; 47(5):951-61. PubMed ID: 16516077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).
    Harrington RA; Lincoff AM; Califf RM; Holmes DR; Berdan LG; O'Hanesian MA; Keeler GP; Garratt KN; Ohman EM; Mark DB
    J Am Coll Cardiol; 1995 Jun; 25(7):1693-9. PubMed ID: 7759725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence, correlates, and significance of abnormal cardiac enzyme rises in patients treated with surgical or percutaneous based revascularisation: a substudy from the Synergy between Percutaneous Coronary Interventions with Taxus and Cardiac Surgery (SYNTAX) Trial.
    Farooq V; Serruys PW; Vranckx P; Bourantas CV; Girasis C; Holmes DR; Kappetein AP; Mack M; Feldman T; Morice MC; Colombo A; Morel MA; de Vries T; Dawkins KD; Mohr FW; James S; Ståhle E
    Int J Cardiol; 2013 Oct; 168(6):5287-92. PubMed ID: 23993326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative predictive value of infarct location, peak CK, and ejection fraction after primary PCI for ST elevation myocardial infarction.
    Nienhuis MB; Ottervanger JP; Dambrink JH; de Boer MJ; Hoorntje JC; Gosselink AT; Suryapranata H; van 't Hof AW
    Coron Artery Dis; 2009 Jan; 20(1):9-14. PubMed ID: 19050596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the elevation of biochemical markers of myocardial damage on long-term mortality after percutaneous coronary intervention: results of the CK-MB and PCI study.
    Cavallini C; Savonitto S; Violini R; Arraiz G; Plebani M; Olivari Z; Rubartelli P; Battaglia S; Niccoli L; Steffenino G; Ardissino D;
    Eur Heart J; 2005 Aug; 26(15):1494-8. PubMed ID: 15741227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of mild transient release of creatine kinase-MB fraction after percutaneous coronary interventions.
    Abdelmeguid AE; Topol EJ; Whitlow PL; Sapp SK; Ellis SG
    Circulation; 1996 Oct; 94(7):1528-36. PubMed ID: 8840840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of recurrent episodes of creatine kinase-MB elevation following repeated catheter-based coronary interventions.
    Kornowski R; Fuchs S; Hong MK; Mehran R; Satler LF; Pichard AD; Kent KM; Stone GW; Leon MB
    Catheter Cardiovasc Interv; 2000 Oct; 51(2):131-7. PubMed ID: 11025563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty.
    Abbas SA; Glazier JJ; Wu AH; Dupont C; Green SF; Pearsall LA; Waters DD; McKay RG
    Clin Cardiol; 1996 Oct; 19(10):782-6. PubMed ID: 8896910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.